What it is
Stereotactic radiosurgery delivers a highly focused dose of radiation to a precisely defined target, in a single session or a small number of sessions. Many individual beams, each too weak to damage the tissue it passes through, converge on the tumor, where their combined dose is high enough to be biologically effective. The result is a steep fall-off in dose at the tumor margin, sparing the surrounding structures.
Gamma Knife is one of several platforms that accomplish this; linear accelerator-based systems achieve the same objective by different means. Despite the terminology, there is no incision and nothing is removed.
The goal is tumor control — arresting growth — rather than elimination. This is an important distinction, because a treated tumor that remains visible on imaging but stops enlarging represents a successful outcome.
What it treats
In neurotology and lateral skull base practice, radiosurgery is most commonly used for:
- Vestibular schwannoma — the most frequent indication, typically for small and medium tumors, and for tumors demonstrating growth on serial imaging
- Paraganglioma — particularly glomus jugulare tumors, where surgery poses meaningful risk to the lower cranial nerves
- Meningioma of the skull base
- Residual or recurrent tumor remaining after a previous operation
- Selected other temporal bone and skull base tumors
It is generally best suited to tumors below a certain size and not causing significant compression of the brainstem. Large tumors, tumors producing substantial mass effect, and tumors causing rapidly progressive symptoms are usually better addressed surgically.
What treatment involves
Treatment is typically completed in a single day.
Planning begins with high-resolution imaging, usually MRI, sometimes with CT. Depending on the platform, a lightweight frame may be fixed to the head using local anesthetic to establish a fixed reference, or a custom mask may be used instead for frameless systems.
Dose planning is a collaborative process between the neurotologist, neurosurgeon, radiation oncologist, and medical physicist. The tumor is contoured, the surrounding critical structures — cochlea, facial nerve, brainstem — are identified, and the dose distribution is shaped to treat the tumor while limiting exposure to those structures.
Delivery takes anywhere from a number of minutes to a couple of hours, depending on the size and shape of the target. You are awake and comfortable throughout, and the treatment itself is painless. Most patients return home the same day and resume normal activity quickly.
Considerations and follow-up
Radiosurgery is generally well tolerated, and its short-term risk profile compares favorably with an operation. There are still trade-offs worth understanding:
- Hearing may be preserved initially but tends to decline over subsequent years in a meaningful proportion of patients with vestibular schwannoma.
- Transient tumor swelling, often called pseudoprogression, is common. It usually appears within the first year or two and does not by itself indicate treatment failure, though it can temporarily worsen symptoms. It sometimes appears considerably later, which is part of why follow-up imaging is read as a trend over time rather than judged from any single scan.
- Facial nerve and trigeminal nerve effects — weakness or numbness — are uncommon with modern dose planning but not impossible.
- Balance symptoms may occur or persist.
- Treatment failure, where the tumor continues to grow, occurs in a minority of cases and may then require surgery. Operating on a previously irradiated tumor is generally more difficult than operating on one that has not been treated, which is a factor worth weighing in the initial decision.
- Lifelong imaging follow-up is necessary, because the tumor remains present and must be monitored indefinitely.
Choosing between options
For many small and medium vestibular schwannomas, observation, radiosurgery, and microsurgery are all defensible, and the right answer depends on the specifics of the tumor and on your own priorities. The considerations that most often drive the decision are tumor size and growth rate, current hearing and how much it matters to you, age and life expectancy, and personal tolerance for an operation versus indefinite surveillance.
This is a decision to make deliberately, with the actual imaging in front of you, rather than in the abstract.